The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

Kameron Gilchrist sprayed his own HIV-tainted blood into the eyes of two hospital workers in North Carolina and was collared ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state ...

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and ...

Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move ...

Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...